EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”

MedComm · 2026-04 · 7 (4)

DOI: 10.1002/mco2.70703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 17.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”. MedComm, 7(4). https://doi.org/10.1002/mco2.70703

Vancouver

Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”. MedComm. 2026;7(4). doi:10.1002/mco2.70703

BibTeX
@article{euvimed2026,
  title = {Correction to “circRNA‐SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis”},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {4},
  doi = {10.1002/mco2.70703}
}
Kostenlos starten →